Commensal Escherichia coliStrains can promote intestinal inflammation via differential interleukin-6 production

Frontiers in Immunology

Volumn 9, Issue OCT, 2018, Pages

  Kittana, Hatem ^a   Gomes Neto, João Carlos ^a   Heck, Kari ^a   Geis, Abby L ^a   Segura Muñoz, Rafael R ^a   Cody, Liz A ^a   Schmaltz, Robert J ^a   Bindels, Laure B ^a   Sinha, Rohita ^a   Hostetter, Jesse M ^b   Benson, Andrew K ^a   Ramer Tait, Amanda E ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Commensal e. coli; Gnotobiotic mice; Interleukin 6; Intestinal inflammation; Strain specific immune responses

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

ANIMAL; BIOPSY; BIOSYNTHESIS; CLASSIFICATION; DISEASE EXACERBATION; DISEASE MODEL; DISEASE PREDISPOSITION; ENTEROCOLITIS; ESCHERICHIA COLI; FEMALE; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; INTESTINE FLORA; INTESTINE MUCOSA; MALE; METABOLISM; MICROBIOLOGY; MOUSE; MULTILOCUS SEQUENCE TYPING; PATHOLOGY; PHYLOGENY;

ANIMALS; BIOPSY; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; ENTEROCOLITIS; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL MICROBIOME; IMMUNOMODULATION; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MICE; MULTILOCUS SEQUENCE TYPING; PHYLOGENY;

EID: 85055329018     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.02318     Document Type: Article

References (43)

1. Walter J, Ley R. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol. (2011) 65:411-29. doi: 10.1146/annurev-micro-090110-102830.
2. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature (2011) 474:327-36. doi: 10.1038/nature10213.
3. Kamada N, Seo S-U, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. (2013) 13:321-35. doi: 10.1038/nri3430.
4. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell (2014) 157:121-41. doi: 10.1016/j.cell.2014.03.011.
5. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. (2009) 9:313-23. doi: 10.1038/nri2515.
6. Ott S, Musfeldt M, Wenderoth D, Hampe J, Brant O, Fölsch U, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 53:685-93. doi: 10.1136/gut.2003.025403.
7. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2006) 55:205-11. doi: 10.1136/gut.2005.073817.
8. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. (2011) 11:7. doi: 10.1186/1471-2180-11-7.
9. Conway T, Krogfelt KA, Cohen PS. The life of commensal Escherichia coli in the mammalian intestine. EcoSal Plus (2004) 1. doi: 10.1128/ecosalplus.8.3.1.2.
10. Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Microbiol. (2010) 8:207-17. doi: 10.1038/.
11. Clavel T, Gomes-Neto JC, Lagkouvardos I, Ramer-Tait AE. Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes. Immunol Rev. (2017) 279:8-22. doi: 10.1111/imr.12578.
12. Hudault S, Guignot J, Servin A. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut (2001) 49:47-55. doi: 10.1136/gut.49.1.47.
13. Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H, et al. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe (2013) 14:26-37. doi: 10.1016/j.chom.2013.06.007.
14. Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut (2013) 63:1069-80. doi: 10.1136/gutjnl-2013-304909.
15. Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut (2013) 63:1069-80. doi: 10.1136/gutjnl-2013-304909.
16. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of theEscherichia coli phylogenetic group. Appl Environ Microbiol. (2000) 66:4555-8. doi: 10.1128/AEM.66.10.4555-4558.2000.
17. Powers EM, Latt TG. Simplified 48-hour IMVic test: an agar plate method. Appl Environ Microbiol. (1977) 34:274-9.
18. Orskov I, Orskov F, Jann B, Jann K. Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev. (1977) 41:667-710.
19. Machado J, Grimont F, Grimont PA. Identification of Escherichia coli flagellar types by restrictionof the amplified fliC gene. Res Microbiol. (2000) 151:535-46. doi: 10.1016/S0923-2508(00)00223-0.
20. Jaureguy F, Landraud L, Passet V, Diancourt L, Frapy E, Guigon G, et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics (2008) 9:560. doi: 10.1186/1471-2164-9-560.
21. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA. (1998) 95:3140-5. doi: 10.1073/pnas.95.6.3140.
22. Dewhirst FE, Chien C-C, Paster BJ, Ericson RL, Orcutt RP, Schauer DB, et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol. (1999) 65:3287-92.
23. Gomes-Neto JC, Kittana H, Mantz S, Segura Munoz RR, Schmaltz RJ, Bindels LB, et al. A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself. Sci Rep. (2017) 7:17707. doi: 10.1038/s41598-017-18014-5.
24. Kittana H, Quintero-Villegas MI, Bindels LB, Gomes-Neto JC, Schmaltz RJ, Munoz RRS, et al. Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden. Microbiology (2017) 164:154-62. doi: 10.1099/mic.0.000593.
25. Jergens AE, Dorn A, Wilson J, Dingbaum K, Henderson A, Liu Z, et al. Induction of differential immune reactivity to members of the flora of gnotobiotic mice following colonization with Helicobacter bilis or Brachyspira hyodysenteriae. Microbes Infect. (2006) 8:1602-10. doi: 10.1016/j.micinf.2006.01.019.
26. Henderson AL, Brand MW, Darling RJ, Maas KJ, Detzel CJ, Hostetter J, et al. Attenuation of colitis by serum-derived bovine immunoglobulin/protein isolate in a defined microbiota mouse model. Dig Dis Sci. (2015) 60:3293-303. doi: 10.1007/s10620-015-3726-5.
27. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 2:119-29. doi: 10.1016/j.chom.2007.06.010.
28. Haag L-M, Fischer A, Otto B, Plickert R, Kühl AA, Göbel UB, et al. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS ONE (2012) 7:e35988. doi: 10.1371/journal.pone.0035988.
29. Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science (2013) 339:708-11. doi: 10.1126/science.1232467.
30. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol. (2000) 164:4878-82. doi: 10.4049/jimmunol.164.9.4878.
31. Dann SM, Spehlmann ME, Hammond DC, Iimura M, Hase K, Choi LJ, et al. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J Immunol. (2008) 180:6816-26. doi: 10.4049/jimmunol.180.10.6816.
32. Pickard JM, Zeng MY, Caruso R, Núñez G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. (2017) 279:70-89. doi: 10.1111/imr.12567.
33. Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol. (2006) 146:330-8. doi: 10.1111/j.1365-2249.2006.03214.x.
34. Xu Y, Hunt NH, Bao S. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res. (2008) 18:1220-9. doi: 10.1038/cr.2008.310.
35. Grivennikov S, Karin E, Terzic J, Mucida D, Yu G-Y, Vallabhapurapu S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell (2009) 15:103-13. doi: 10.1016/j.ccr.2009.01.001.
36. Kuhn KA, Manieri NA, Liu T-C, Stappenbeck TS. IL-6 stimulates intestinal epithelial proliferation and repair after injury. PLoS ONE (2014) 9:e114195. doi: 10.1371/journal.pone.0114195.
37. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott R, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclearcells from patients with ulcertive colitis and Crohn's disease. Clin Exp Immunol. (1993) 94:174-81. doi: 10.1111/j.1365-2249.1993.tb05997.x.
38. Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, et al. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model. J Immunol. (2010) 184:1543-51. doi: 10.4049/jimmunol.0801217.
39. Kullberg MC, Rothfuchs AG, Jankovic D, Caspar P, Wynn TA, Gorelick PL, et al. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation. Infect Immun. (2001) 69:4232-41. doi: 10.1128/IAI.69.7.4232-4241.2001.
40. Souza ÉL, Elian SD, Paula LM, Garcia CC, Vieira AT, Teixeira MM, et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model. J Med Microbiol. (2016) 65:201-10. doi: 10.1099/jmm.0.000222.
41. Nogales AR, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, et al. The administration of Escherichia coli Nissle 1917 ameliorates development of DSS-induced colitis in mice. Front Pharmacol. (2018) 9:468. doi: 10.3389/fphar.2018.00468.
42. Bereswill S, Fischer A, Dunay I, Kühl A, Göbel U, Liesenfeld O, et al. Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis. Eur J Microbiol Immunol. (2013) 3:126-34. doi: 10.1556/EuJMI.3.2013.2.6.
43. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology (2005) 128:891-906. doi: 10.1053/j.gastro.2005.02.009.